US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Park Hotels & Resorts Inc.

15.30

-0.5300-3.35%

Post-market: 15.400.1000+0.65%19:35 EDT

Volume:4.74M

Turnover:72.89M

Market Cap:3.08B

PE:-18.51

High:15.81

Open:15.81

Low:15.26

Close:15.83

52wk High:16.20

52wk Low:9.84

Shares:201.40M

Float Shares:195.63M

Volume Ratio:1.36

T/O Rate:2.42%

Dividend:1

Dividend Rate:6.54%

EPS(TTM):-0.8265

EPS(LYR):-1.4300

ROE:-4.86%

ROA:2.75%

PB:1.00

PE(LYR):-10.70

Loading ...

Overview Company News Filings

Park Hotels & Resorts Is Maintained at Equal-Weight by Morgan Stanley

Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease

Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results

Press Release: Sionna Therapeutics Reports First Quarter 2026 Financial Results

Erasca Reports First Quarter 2026 Business Updates and Financial Results

MBX Biosciences Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing

Press Release: Actuate Therapeutics Announces FDA Clearance of IND for Oral Elraglusib and Strategic Initiatives to Advance the Elraglusib Development Program

Live Broadcast Preview: Guangdong BA League - Meizhou vs. Qingyuan! Tonight, Witness the "Qing-Mei" Rivalry Face-Off

Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results

Press Release: Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update

Climb Bio Reports First Quarter 2026 Financial Results and Provides Business Updates

Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update

Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights

OnKure Therapeutics Reports First Quarter 2026 Financial Results

SPONTAN® Phase II interim data demonstrates rapid onset and pharmacokinetic profile addressing FDA Pre-IND requirements across adult and ≥65 populations

How Investors Are Reacting To Park Hotels & Resorts (PK) Q1 Beat, Guidance Shift And New Loan Facility

Simply Wall St.

Analysts Offer Insights on Real Estate Companies: Safehold (SAFE), Piedmont Office (PDM) and Park Hotels & Resorts (PK)

GUIDANCE: (PK) Park Hotels & Resorts Expects 2026 Adjusted FFO Range $1.74-$1.90, vs. FactSet Est of $1.84

MT Newswires Live

Earnings Flash (PK) Park Hotels & Resorts Posts Q1 Adjusted FFO $0.45, vs. FactSet Est of $0.39

MT Newswires Live

Park Hotels & Resorts Q1 FFO $0.45 Beats $0.39 Estimate, Sales $622.000M Beat $611.238M Estimate

Benzinga Earnings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/PK/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PK\",,,,,undefined,":{"symbol":"PK","market":"US","secType":"STK","nameCN":"Park Hotels & Resorts Inc.","latestPrice":15.3,"timestamp":1788206400000,"preClose":15.83,"halted":0,"volume":4736977,"hourTrading":{"tag":"盘后","latestPrice":15.4,"preClose":15.3,"latestTime":"19:35 EDT","volume":618720,"amount":9467198.041263,"timestamp":1788219350511,"change":0.1,"changeRate":0.006536,"amplitude":0.006536},"delay":0,"changeRate":-0.033480732785849614,"floatShares":195633448,"shares":201398439,"eps":-0.826466,"marketStatus":"Closed","change":-0.53,"latestTime":"08-31 16:00:00 EDT","open":15.81,"high":15.81,"low":15.255,"amount":72891493.623382,"amplitude":0.03506,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.826466,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":15.83,"dividendRate":0.065359,"preHourTrading":{"tag":"盘前","latestPrice":15.7099,"preClose":15.83,"latestTime":"06:23 EDT","volume":36,"amount":565.276788,"timestamp":1788171790896,"change":-0.1201,"changeRate":-0.007587,"amplitude":0.004416},"postHourTrading":{"tag":"盘后","latestPrice":15.4,"preClose":15.3,"latestTime":"19:35 EDT","volume":618720,"amount":9467198.041263,"timestamp":1788219350511,"change":0.1,"changeRate":0.006536,"amplitude":0.006536},"volumeRatio":1.35665,"impliedVol":0.3429,"impliedVolPercentile":0.1753},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PK\",,,,,undefined,":{"symbol":"PK","floatShares":195633448,"roa":"2.75%","roe":"-4.86%","lyrEps":-1.43,"volumeRatio":1.35665,"shares":201398439,"dividePrice":1,"high":15.81,"amplitude":0.03506,"preClose":15.83,"low":15.255,"week52Low":9.84,"pbRate":"1.00","psRate":"1.21","week52High":16.2,"institutionHeld":0,"latestPrice":15.3,"eps":-0.826466,"divideRate":0.065359,"volume":4736977,"delay":0,"ttmEps":-0.826466,"open":15.81,"prevYearClose":10.46,"prevWeekClose":15.83,"prevMonthClose":15.06,"prevQuarterClose":14.25,"fiveDayClose":15.86,"twentyDayClose":15.12,"sixtyDayClose":14.04,"dividendPayoutRate":1.373460620431404,"dividendFrequency":"Q","dividendGrowthYears":0,"dividendGrowthRate":-0.28571428571428564,"fiveYearAvgDividendRate":0.07559574201047665},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PK\",params:#limit:5,,,undefined,":[{"date":"2026-09-30","symbol":"PK","amount":0.25,"announcedDate":"2026-07-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-30","defaultRemindTime":1790775000000,"name":"Park Hotels & Resorts Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-15","payableDate":"2026-09-30","currency":"USD","dateTimestamp":1790740800000,"payDate":"2026-10-15"},{"market":"US","date":"2026-08-06","symbol":"PK","fiscalQuarterEnding":"2026/06","expectedEps":0.57,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":0.7},{"date":"2026-06-30","symbol":"PK","amount":0.25,"announcedDate":"2026-04-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-30","defaultRemindTime":1782826200000,"name":"Park Hotels & Resorts Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-15","payableDate":"2026-06-30","currency":"USD","dateTimestamp":1782792000000,"payDate":"2026-07-15"},{"market":"US","date":"2026-04-30","symbol":"PK","fiscalQuarterEnding":"2026/03","expectedEps":0.38,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"post","actualEps":0.45},{"date":"2026-03-31","symbol":"PK","amount":0.25,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-31","defaultRemindTime":1774963800000,"name":"Park Hotels & Resorts Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-15","payableDate":"2026-03-31","currency":"USD","dateTimestamp":1774929600000,"payDate":"2026-04-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PK\",market:\"US\",,,undefined,":[{"executeDate":"2017-03-29","recordDate":"2017-03-31","paymentDate":"2017-04-17","value":0.43,"currency":"USD"},{"executeDate":"2017-06-28","recordDate":"2017-06-30","paymentDate":"2017-07-17","value":0.43,"currency":"USD"},{"executeDate":"2017-09-28","recordDate":"2017-09-29","paymentDate":"2017-10-16","value":0.43,"currency":"USD"},{"executeDate":"2017-12-28","recordDate":"2017-12-29","paymentDate":"2018-01-16","value":0.55,"currency":"USD"},{"executeDate":"2018-03-28","recordDate":"2018-03-30","paymentDate":"2018-04-16","value":0.43,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1111,"buy":0.0556,"hold":0.7222,"sell":0.1111,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.7222,"analysts":18,"updateTime":1775793600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PK","date":"2026-08-28","current":-18.512558,"percent":0.221582,"low":-196.066894,"twenty":-46.400028,"median":-5.644455,"eighty":17.858097,"high":55.399897,"avg":-11.404436,"sd":52.708303,"marketCap":3163025164},"quantilePoints":[{"date":"2021-09-03","current":-5.52902,"twenty":-3.565932,"median":12.702277,"eighty":24.944766,"marketCap":4417687278},{"date":"2021-09-10","current":-5.437265,"twenty":-3.571599,"median":12.695796,"eighty":24.807396,"marketCap":4344374481},{"date":"2021-09-17","current":-5.688853,"twenty":-3.581314,"median":12.675381,"eighty":24.746792,"marketCap":4545393441},{"date":"2021-09-24","current":-5.97004,"twenty":-3.589648,"median":12.636863,"eighty":24.72659,"marketCap":4770061692},{"date":"2021-10-01","current":-5.896043,"twenty":-3.599497,"median":12.622139,"eighty":24.665986,"marketCap":4710938468},{"date":"2021-10-08","current":-5.721411,"twenty":-3.607845,"median":12.595518,"eighty":24.655885,"marketCap":4571407660},{"date":"2021-10-15","current":-5.659254,"twenty":-3.625758,"median":12.578404,"eighty":24.655885,"marketCap":4521744152},{"date":"2021-10-22","current":-5.505341,"twenty":-3.649856,"median":12.569511,"eighty":24.645785,"marketCap":4398767847},{"date":"2021-10-29","current":-5.484622,"twenty":-3.670075,"median":12.545167,"eighty":24.625583,"marketCap":4382213344},{"date":"2021-11-05","current":-8.201051,"twenty":-3.681985,"median":12.518997,"eighty":24.605382,"marketCap":4994440260},{"date":"2021-11-12","current":-7.56811,"twenty":-3.701263,"median":12.505104,"eighty":24.575079,"marketCap":4608979198},{"date":"2021-11-19","current":-7.339009,"twenty":-3.720957,"median":12.481428,"eighty":24.44377,"marketCap":4469456483},{"date":"2021-11-26","current":-6.989532,"twenty":-3.729965,"median":12.465978,"eighty":24.427609,"marketCap":4256625222},{"date":"2021-12-03","current":-6.488616,"twenty":-3.750955,"median":12.411262,"eighty":24.415488,"marketCap":3951567081},{"date":"2021-12-10","current":-7.129323,"twenty":-3.770233,"median":12.390156,"eighty":24.397368,"marketCap":4341757726},{"date":"2021-12-17","current":-6.752665,"twenty":-3.792938,"median":12.369502,"eighty":24.247831,"marketCap":4112372922},{"date":"2021-12-23","current":-7.490449,"twenty":-3.83227,"median":12.348324,"eighty":24.162969,"marketCap":4561683362},{"date":"2021-12-31","current":-7.331243,"twenty":-3.873903,"median":12.336915,"eighty":24.124587,"marketCap":4464726899},{"date":"2022-01-07","current":-7.692369,"twenty":-3.888468,"median":12.314228,"eighty":24.072063,"marketCap":4684652535},{"date":"2022-01-14","current":-7.548695,"twenty":-3.917478,"median":12.283673,"eighty":24.03368,"marketCap":4597155239},{"date":"2022-01-21","current":-7.032246,"twenty":-3.996222,"median":12.241172,"eighty":24.02964,"marketCap":4282637931},{"date":"2022-01-28","current":-6.803145,"twenty":-4.087905,"median":12.214275,"eighty":24.013479,"marketCap":4143115216},{"date":"2022-02-04","current":-7.051662,"twenty":-4.210886,"median":12.177189,"eighty":23.964995,"marketCap":4294461890},{"date":"2022-02-11","current":-7.339009,"twenty":-4.305038,"median":12.115818,"eighty":23.924593,"marketCap":4469456483},{"date":"2022-02-18","current":-9.97933,"twenty":-4.379327,"median":12.077002,"eighty":23.906411,"marketCap":4580512556},{"date":"2022-02-25","current":-9.762948,"twenty":-4.434604,"median":12.034907,"eighty":23.88419,"marketCap":4481193234},{"date":"2022-03-04","current":-9.294121,"twenty":-4.477502,"median":11.989722,"eighty":23.857928,"marketCap":4266001369},{"date":"2022-03-11","current":-9.515655,"twenty":-4.530065,"median":11.874947,"eighty":23.585208,"marketCap":4367685437},{"date":"2022-03-18","current":-9.793479,"twenty":-4.62021,"median":11.802039,"eighty":23.304408,"marketCap":4495206674},{"date":"2022-03-25","current":-9.839796,"twenty":-4.668569,"median":11.613959,"eighty":23.136735,"marketCap":4516466191},{"date":"2022-04-01","current":-10.045649,"twenty":-4.723283,"median":11.244693,"eighty":22.801391,"marketCap":4610952931},{"date":"2022-04-08","current":-8.795089,"twenty":-4.748358,"median":11.177001,"eighty":22.577155,"marketCap":4036945983},{"date":"2022-04-14","current":-9.860381,"twenty":-4.774334,"median":11.132722,"eighty":22.280194,"marketCap":4525914865},{"date":"2022-04-22","current":-9.999332,"twenty":-4.831692,"median":11.002063,"eighty":21.938028,"marketCap":4589693414},{"date":"2022-04-29","current":-10.143429,"twenty":-4.933265,"median":10.846102,"eighty":20.988446,"marketCap":4655834133},{"date":"2022-05-06","current":-13.808923,"twenty":-5.010567,"median":10.72108,"eighty":20.329014,"marketCap":4501708843},{"date":"2022-05-13","current":-13.178967,"twenty":-5.093895,"median":7.386072,"eighty":20.146479,"marketCap":4296343172},{"date":"2022-05-20","current":-11.861786,"twenty":-5.147058,"median":6.828781,"eighty":19.994366,"marketCap":3866942225},{"date":"2022-05-27","current":-13.143174,"twenty":-5.175677,"median":6.45202,"eighty":19.781409,"marketCap":4284674668},{"date":"2022-06-03","current":-13.207601,"twenty":-5.20439,"median":6.373529,"eighty":19.661408,"marketCap":4305677976},{"date":"2022-06-10","current":-12.055068,"twenty":-5.217352,"median":6.1773,"eighty":18.57907,"marketCap":3929952147},{"date":"2022-06-17","current":-10.229627,"twenty":-5.287145,"median":5.839785,"eighty":18.013987,"marketCap":3334858443},{"date":"2022-06-24","current":-10.1652,"twenty":-5.323251,"median":5.651405,"eighty":17.603643,"marketCap":3313855136},{"date":"2022-07-01","current":-9.70705,"twenty":-5.360954,"median":5.101963,"eighty":17.208917,"marketCap":3164498284},{"date":"2022-07-08","current":-9.85738,"twenty":-5.388567,"median":3.861793,"eighty":17.068349,"marketCap":3213506001},{"date":"2022-07-15","current":-9.921808,"twenty":-5.409668,"median":2.45556,"eighty":16.809931,"marketCap":3234509308},{"date":"2022-07-22","current":-10.487336,"twenty":-5.439477,"median":2.417283,"eighty":16.594109,"marketCap":3418871672},{"date":"2022-07-29","current":-11.160244,"twenty":-5.472783,"median":2.404801,"eighty":15.354106,"marketCap":3638239547},{"date":"2022-08-05","current":-56.398031,"twenty":-5.505341,"median":2.387327,"eighty":15.148576,"marketCap":3383881882},{"date":"2022-08-12","current":-60.145409,"twenty":-5.52902,"median":2.299955,"eighty":15.006602,"marketCap":3608724532},{"date":"2022-08-19","current":-55.873399,"twenty":-5.552107,"median":2.257518,"eighty":14.887345,"marketCap":3352403911},{"date":"2022-08-26","current":-53.287708,"twenty":-5.563474,"median":2.212781,"eighty":14.845845,"marketCap":3197262483},{"date":"2022-09-02","current":-52.238442,"twenty":-5.614856,"median":2.207821,"eighty":14.818112,"marketCap":3134306541},{"date":"2022-09-09","current":-54.786659,"twenty":-5.644455,"median":2.197209,"eighty":14.800268,"marketCap":3287199543},{"date":"2022-09-16","current":-52.051073,"twenty":-5.663398,"median":2.187137,"eighty":14.752289,"marketCap":3123064408},{"date":"2022-09-23","current":-44.593792,"twenty":-5.688853,"median":2.168482,"eighty":14.705619,"marketCap":2675627535},{"date":"2022-09-30","current":-42.195471,"twenty":-5.714833,"median":2.125089,"eighty":14.651669,"marketCap":2531728239},{"date":"2022-10-07","current":-43.582,"twenty":-5.729107,"median":2.082185,"eighty":14.616649,"marketCap":2614920019},{"date":"2022-10-14","current":-44.219054,"twenty":-5.777649,"median":2.070313,"eighty":14.587307,"marketCap":2653143270},{"date":"2022-10-21","current":-47.216957,"twenty":-5.925642,"median":2.05882,"eighty":14.530184,"marketCap":2833017390},{"date":"2022-10-28","current":-48.828329,"twenty":-6.246611,"median":2.029326,"eighty":14.486979,"marketCap":2929699729},{"date":"2022-11-04","current":43.862859,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2675634425},{"date":"2022-11-11","current":47.03278,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2868999602},{"date":"2022-11-18","current":45.005505,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2745335826},{"date":"2022-11-25","current":45.742696,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2790304471},{"date":"2022-12-02","current":46.553606,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2839769982},{"date":"2022-12-09","current":45.41096,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2770068581},{"date":"2022-12-16","current":44.342034,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2704864044},{"date":"2022-12-23","current":42.941371,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2619423617},{"date":"2022-12-30","current":43.457404,"twenty":-6.452657,"median":2.015912,"eighty":14.434922,"marketCap":2650901669},{"date":"2023-01-06","current":44.010298,"twenty":-6.452657,"median":2.015912,"eighty":14.499284,"marketCap":2684628154},{"date":"2023-01-13","current":46.332449,"twenty":-6.452657,"median":2.015912,"eighty":14.544715,"marketCap":2826279388},{"date":"2023-01-20","current":47.585674,"twenty":-6.452657,"median":2.015912,"eighty":14.591155,"marketCap":2902726086},{"date":"2023-01-27","current":53.188324,"twenty":-6.452657,"median":2.015912,"eighty":14.629303,"marketCap":3244487794},{"date":"2023-02-03","current":54.478409,"twenty":-6.452657,"median":2.015912,"eighty":14.659241,"marketCap":3323182924},{"date":"2023-02-10","current":52.598572,"twenty":-6.452657,"median":2.015912,"eighty":14.710351,"marketCap":3208512877},{"date":"2023-02-17","current":50.681875,"twenty":-6.452657,"median":2.015912,"eighty":14.776825,"marketCap":3091594398},{"date":"2023-02-24","current":19.081678,"twenty":-6.452657,"median":2.015912,"eighty":14.800268,"marketCap":3091231855},{"date":"2023-03-03","current":19.2873,"twenty":-6.452657,"median":2.020509,"eighty":14.820409,"marketCap":3124542543},{"date":"2023-03-10","current":17.080295,"twenty":-6.452657,"median":2.020509,"eighty":14.858004,"marketCap":2767007824},{"date":"2023-03-17","current":15.80726,"twenty":-6.452657,"median":2.020509,"eighty":14.898703,"marketCap":2560776060},{"date":"2023-03-24","current":15.423721,"twenty":-6.452657,"median":2.034301,"eighty":15.020423,"marketCap":2498642845},{"date":"2023-03-31","current":16.930479,"twenty":-6.449731,"median":2.061884,"eighty":15.148576,"marketCap":2742737617},{"date":"2023-04-06","current":16.355172,"twenty":-6.449731,"median":2.08027,"eighty":15.339767,"marketCap":2649537795},{"date":"2023-04-14","current":16.231891,"twenty":-6.452657,"median":2.187137,"eighty":15.656584,"marketCap":2629566405},{"date":"2023-04-21","current":16.1771,"twenty":-6.452657,"median":2.20399,"eighty":16.160663,"marketCap":2620690231},{"date":"2023-04-28","current":15.916842,"twenty":-6.452657,"median":3.861793,"eighty":16.193538,"marketCap":2578528407},{"date":"2023-05-05","current":10.781494,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":2716936387},{"date":"2023-05-12","current":11.431806,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":2880815089},{"date":"2023-05-19","current":11.705622,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":2949816648},{"date":"2023-05-26","current":11.13232,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":2805344634},{"date":"2023-06-02","current":11.115206,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":2801032037},{"date":"2023-06-09","current":12.184799,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":3070569377},{"date":"2023-06-16","current":11.243558,"twenty":-6.452657,"median":4.795845,"eighty":16.193538,"marketCap":2833376518},{"date":"2023-06-23","current":10.71304,"twenty":-6.455582,"median":4.787996,"eighty":16.201756,"marketCap":2699685997},{"date":"2023-06-30","current":10.926958,"twenty":-6.458508,"median":4.780147,"eighty":16.209975,"marketCap":2753593465},{"date":"2023-07-07","current":11.226444,"twenty":-6.458508,"median":4.780147,"eighty":16.209975,"marketCap":2829063920},{"date":"2023-07-14","current":11.799746,"twenty":-6.458508,"median":4.780147,"eighty":16.209975,"marketCap":2973535934},{"date":"2023-07-21","current":11.260671,"twenty":-6.458508,"median":4.780147,"eighty":16.209975,"marketCap":2837689115},{"date":"2023-07-28","current":10.76438,"twenty":-6.458508,"median":4.780147,"eighty":16.209975,"marketCap":2712623789},{"date":"2023-08-04","current":-57.485197,"twenty":-6.501042,"median":3.861793,"eighty":16.209975,"marketCap":2759289480},{"date":"2023-08-11","current":-60.090736,"twenty":-6.750335,"median":-2.450979,"eighty":16.209975,"marketCap":2884355344},{"date":"2023-08-18","current":-56.854736,"twenty":-6.930509,"median":-2.566048,"eighty":16.209975,"marketCap":2729027307},{"date":"2023-08-25","current":-56.854736,"twenty":-7.00324,"median":-2.678241,"eighty":16.209975,"marketCap":2729027307},{"date":"2023-08-31","current":-58.203069,"twenty":-7.047778,"median":-2.730022,"eighty":16.209975,"marketCap":2793747322},{"date":"2023-09-08","current":-56.225513,"twenty":-7.135536,"median":-2.76742,"eighty":16.220933,"marketCap":2698824633},{"date":"2023-09-13","current":-59.641292,"twenty":-7.238826,"median":-2.81236,"eighty":16.220933,"marketCap":2862782005},{"date":"2023-09-20","current":-56.49518,"twenty":-7.292412,"median":-2.856599,"eighty":16.226412,"marketCap":2711768636},{"date":"2023-09-29","current":-56.270458,"twenty":-7.33179,"median":-2.859478,"eighty":16.256547,"marketCap":2700981967},{"date":"2023-10-06","current":-54.068179,"twenty":-7.350658,"median":-2.872421,"eighty":16.256547,"marketCap":2595272609},{"date":"2023-10-13","current":-54.023235,"twenty":-7.41434,"median":-2.928517,"eighty":16.256547,"marketCap":2593115275},{"date":"2023-10-20","current":-52.944568,"twenty":-7.474917,"median":-3.004751,"eighty":16.256547,"marketCap":2541339263},{"date":"2023-10-23","current":-52.405235,"twenty":-7.491226,"median":-3.007627,"eighty":16.256547,"marketCap":2515451257},{"date":"2023-11-03","current":-48.333767,"twenty":-7.537046,"median":-3.046463,"eighty":16.355172,"marketCap":2706690937},{"date":"2023-11-10","current":-48.821216,"twenty":-7.614707,"median":-3.102759,"eighty":16.355172,"marketCap":2733988086},{"date":"2023-11-17","current":-52.758411,"twenty":-7.692369,"median":-3.147149,"eighty":16.355172,"marketCap":2954470996},{"date":"2023-11-24","current":-54.558271,"twenty":-8.07291,"median":-3.21274,"eighty":16.355172,"marketCap":3055263184},{"date":"2023-12-01","current":-55.60819,"twenty":-8.887723,"median":-3.353198,"eighty":16.355172,"marketCap":3114058626},{"date":"2023-12-08","current":-56.170646,"twenty":-9.20165,"median":-3.416563,"eighty":16.355172,"marketCap":3145556185},{"date":"2023-12-13","current":-57.820518,"twenty":-9.294121,"median":-3.460856,"eighty":16.355172,"marketCap":3237949024},{"date":"2023-12-22","current":-62.432661,"twenty":-9.507389,"median":-3.497732,"eighty":16.36339,"marketCap":3496229004},{"date":"2024-01-05","current":-59.020425,"twenty":-9.574387,"median":-3.519891,"eighty":16.393525,"marketCap":3305143815},{"date":"2024-01-12","current":-60.445315,"twenty":-9.664756,"median":-3.542049,"eighty":16.393525,"marketCap":3384937630},{"date":"2024-01-19","current":-59.99535,"twenty":-9.712777,"median":-3.553469,"eighty":16.401744,"marketCap":3359739584},{"date":"2024-01-26","current":-58.232986,"twenty":-9.763771,"median":-3.571596,"eighty":16.393525,"marketCap":3261047233},{"date":"2024-02-02","current":-66.888565,"twenty":-9.823019,"median":-3.581378,"eighty":16.393525,"marketCap":3210651139},{"date":"2024-02-09","current":-57.220565,"twenty":-9.869644,"median":-3.59147,"eighty":16.393525,"marketCap":3204351628},{"date":"2024-02-16","current":-57.220565,"twenty":-9.956321,"median":-3.604489,"eighty":16.393525,"marketCap":3204351628},{"date":"2024-02-23","current":-60.89528,"twenty":-10.043591,"median":-3.622011,"eighty":16.393525,"marketCap":3410135677},{"date":"2024-03-01","current":35.936019,"twenty":-10.056469,"median":-3.625758,"eighty":16.447807,"marketCap":3485793844},{"date":"2024-03-08","current":37.18843,"twenty":-10.056469,"median":-3.625758,"eighty":16.567212,"marketCap":3607277745},{"date":"2024-03-15","current":36.961243,"twenty":-10.056469,"median":-3.625758,"eighty":16.670221,"marketCap":3585240545},{"date":"2024-03-22","current":38.523902,"twenty":-10.056469,"median":-3.625758,"eighty":16.766106,"marketCap":3736818537},{"date":"2024-03-28","current":38.306866,"twenty":-10.056469,"median":-3.625758,"eighty":16.809931,"marketCap":3715766038},{"date":"2024-04-05","current":37.156575,"twenty":-10.059306,"median":-3.629041,"eighty":16.978896,"marketCap":3604187794},{"date":"2024-04-12","current":37.894498,"twenty":-10.059306,"median":-3.629041,"eighty":17.16064,"marketCap":3675766290},{"date":"2024-04-19","current":35.007918,"twenty":-10.059306,"median":-3.629041,"eighty":17.258612,"marketCap":3395768056},{"date":"2024-04-26","current":35.44199,"twenty":-10.056469,"median":-3.625758,"eighty":17.840762,"marketCap":3437873054},{"date":"2024-05-03","current":36.498796,"twenty":-10.056469,"median":-3.625758,"eighty":18.170174,"marketCap":3357889189},{"date":"2024-05-10","current":36.511207,"twenty":-10.056469,"median":-3.625758,"eighty":18.755351,"marketCap":3359031034},{"date":"2024-05-17","current":37.541304,"twenty":-10.056469,"median":-3.625758,"eighty":19.13678,"marketCap":3453799934},{"date":"2024-05-24","current":36.396752,"twenty":-10.056469,"median":-3.625758,"eighty":19.228198,"marketCap":3348501156},{"date":"2024-05-31","current":35.595565,"twenty":-10.056469,"median":-3.625758,"eighty":19.551549,"marketCap":3274792011},{"date":"2024-06-07","current":34.863052,"twenty":-10.056469,"median":-3.625758,"eighty":19.788169,"marketCap":3207400793},{"date":"2024-06-14","current":34.496795,"twenty":-10.059306,"median":-3.629041,"eighty":19.972394,"marketCap":3173705183},{"date":"2024-06-21","current":33.832955,"twenty":-10.062143,"median":-3.632324,"eighty":20.117746,"marketCap":3112631892},{"date":"2024-06-28","current":34.061866,"twenty":-10.071657,"median":-3.634664,"eighty":20.170141,"marketCap":3133691648},{"date":"2024-07-05","current":33.398026,"twenty":-10.071657,"median":-3.634664,"eighty":20.359437,"marketCap":3072618356},{"date":"2024-07-12","current":32.779968,"twenty":-10.071657,"median":-3.634664,"eighty":20.997672,"marketCap":3015757016},{"date":"2024-07-15","current":33.466699,"twenty":-10.071657,"median":-3.634664,"eighty":21.055774,"marketCap":3078936283},{"date":"2024-08-02","current":10.070358,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":3081529526},{"date":"2024-08-09","current":9.455895,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":2893503995},{"date":"2024-08-16","current":9.763127,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":2987516760},{"date":"2024-08-23","current":10.179596,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":3114956286},{"date":"2024-08-30","current":10.309316,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":3154650565},{"date":"2024-09-06","current":9.742645,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":2981249243},{"date":"2024-09-13","current":9.408104,"twenty":-10.150883,"median":-3.673418,"eighty":21.36338,"marketCap":2878879787},{"date":"2024-09-20","current":10.718957,"twenty":-10.150883,"median":-3.673418,"eighty":21.101408,"marketCap":3280000919},{"date":"2024-09-27","current":10.084013,"twenty":-10.150883,"median":-3.673418,"eighty":20.560563,"marketCap":3085707871},{"date":"2024-10-04","current":9.585615,"twenty":-10.150883,"median":-3.673418,"eighty":20.205634,"marketCap":2933198274},{"date":"2024-10-11","current":9.756299,"twenty":-10.150883,"median":-3.673418,"eighty":20.146479,"marketCap":2985427588},{"date":"2024-10-18","current":9.626579,"twenty":-10.150883,"median":-3.673418,"eighty":20.146479,"marketCap":2945733309},{"date":"2024-10-25","current":9.462723,"twenty":-10.150883,"median":-3.673418,"eighty":20.138028,"marketCap":2895593168},{"date":"2024-10-31","current":8.714822,"twenty":-10.150883,"median":-3.673418,"eighty":19.647887,"marketCap":2902035670},{"date":"2024-11-08","current":9.117754,"twenty":-10.153746,"median":-3.674208,"eighty":19.166669,"marketCap":3036211945},{"date":"2024-11-15","current":9.111555,"twenty":-10.153746,"median":-3.674208,"eighty":18.78122,"marketCap":3034147899},{"date":"2024-11-22","current":9.099159,"twenty":-10.153746,"median":-3.674208,"eighty":16.930479,"marketCap":3030019806},{"date":"2024-11-29","current":9.638414,"twenty":-10.153746,"median":-3.674208,"eighty":16.766106,"marketCap":3209591825},{"date":"2024-12-06","current":9.756182,"twenty":-10.153746,"median":-3.674208,"eighty":16.574337,"marketCap":3248808703},{"date":"2024-12-13","current":9.53924,"twenty":-10.153746,"median":-3.674208,"eighty":16.377088,"marketCap":3176567086},{"date":"2024-12-20","current":8.968994,"twenty":-10.153746,"median":-3.674208,"eighty":16.1771,"marketCap":2986674836},{"date":"2024-12-27","current":9.334695,"twenty":-10.153746,"median":-3.674208,"eighty":15.960675,"marketCap":3108453562},{"date":"2025-01-03","current":8.541308,"twenty":-10.153746,"median":-3.674208,"eighty":15.74151,"marketCap":2844255649},{"date":"2025-01-10","current":8.398747,"twenty":-10.15661,"median":-3.674999,"eighty":15.187166,"marketCap":2796782587},{"date":"2025-01-17","current":8.429738,"twenty":-10.15661,"median":-3.674999,"eighty":14.123802,"marketCap":2807102818},{"date":"2025-01-24","current":8.541308,"twenty":-10.15661,"median":-3.674999,"eighty":12.229294,"marketCap":2844255649},{"date":"2025-01-31","current":8.355358,"twenty":-10.15661,"median":-3.674999,"eighty":11.774076,"marketCap":2782334264},{"date":"2025-02-07","current":8.175606,"twenty":-10.15661,"median":-3.674999,"eighty":11.669683,"marketCap":2722476924},{"date":"2025-02-14","current":7.915276,"twenty":-10.15661,"median":-3.674999,"eighty":11.541332,"marketCap":2635786984},{"date":"2025-02-21","current":12.449378,"twenty":-10.15661,"median":-3.674999,"eighty":11.52593,"marketCap":2639268117},{"date":"2025-02-28","current":11.712888,"twenty":-10.15661,"median":-3.674999,"eighty":11.52593,"marketCap":2483132177},{"date":"2025-03-07","current":11.32214,"twenty":-10.159473,"median":-3.675279,"eighty":11.440344,"marketCap":2400293756},{"date":"2025-03-14","current":10.388159,"twenty":-10.159473,"median":-3.675279,"eighty":11.489992,"marketCap":2202289726},{"date":"2025-03-21","current":11.045758,"twenty":-10.159473,"median":-3.675279,"eighty":11.489992,"marketCap":2341700727},{"date":"2025-03-28","current":10.62642,"twenty":-10.159473,"median":-3.675279,"eighty":11.489992,"marketCap":2252800958},{"date":"2025-04-04","current":9.263569,"twenty":-10.159473,"median":-3.675279,"eighty":11.489992,"marketCap":1963876709},{"date":"2025-04-11","current":8.979147,"twenty":-10.15661,"median":-3.674999,"eighty":11.484858,"marketCap":1903579170},{"date":"2025-04-17","current":9.09341,"twenty":-10.15661,"median":-3.674999,"eighty":11.484858,"marketCap":1927802871},{"date":"2025-04-25","current":9.512373,"twenty":-10.159473,"median":-3.675279,"eighty":11.489992,"marketCap":2016623108},{"date":"2025-05-02","current":9.559983,"twenty":-10.159473,"median":-3.675279,"eighty":11.489992,"marketCap":2026716317},{"date":"2025-05-09","current":16.384875,"twenty":-10.159473,"median":-3.675279,"eighty":11.531064,"marketCap":2080879082},{"date":"2025-05-16","current":17.045936,"twenty":-10.159473,"median":-3.674208,"eighty":11.65257,"marketCap":2164833858},{"date":"2025-05-23","current":16.148781,"twenty":-10.159473,"median":-3.6534,"eighty":11.72393,"marketCap":2050895233},{"date":"2025-05-30","current":16.510791,"twenty":-10.159473,"median":-3.629041,"eighty":11.766258,"marketCap":2096870468},{"date":"2025-06-06","current":15.771032,"twenty":-10.159473,"median":-3.604398,"eighty":11.937378,"marketCap":2002921076},{"date":"2025-06-13","current":16.447833,"twenty":-10.159473,"median":-3.588007,"eighty":12.388042,"marketCap":2088874775},{"date":"2025-06-20","current":16.038604,"twenty":-10.162337,"median":-3.578159,"eighty":15.511387,"marketCap":2036902771},{"date":"2025-06-27","current":16.55801,"twenty":-10.162337,"median":-3.568226,"eighty":15.739397,"marketCap":2102867237},{"date":"2025-07-03","current":17.061675,"twenty":-10.162337,"median":-3.549185,"eighty":15.841236,"marketCap":2166832781},{"date":"2025-07-11","current":17.848653,"twenty":-10.162337,"median":-3.540618,"eighty":16.000829,"marketCap":2266778942},{"date":"2025-07-18","current":16.998717,"twenty":-10.162337,"median":-3.507581,"eighty":16.081216,"marketCap":2158837088},{"date":"2025-07-25","current":17.518122,"twenty":-10.162337,"median":-3.495637,"eighty":16.142485,"marketCap":2224801554},{"date":"2025-08-01","current":36.742661,"twenty":-10.162337,"median":-3.456698,"eighty":16.1771,"marketCap":2131074349},{"date":"2025-08-08","current":35.570815,"twenty":-10.162337,"median":-3.417502,"eighty":16.307701,"marketCap":2063107278},{"date":"2025-08-15","current":38.224839,"twenty":-10.162337,"median":-3.417502,"eighty":16.351669,"marketCap":2217040670},{"date":"2025-08-22","current":38.500582,"twenty":-10.162337,"median":-3.417502,"eighty":16.434619,"marketCap":2233033750},{"date":"2025-08-29","current":40.534185,"twenty":-10.162337,"median":-3.417502,"eighty":16.560113,"marketCap":2350982712},{"date":"2025-09-05","current":41.740559,"twenty":-10.1652,"median":-3.433,"eighty":16.629128,"marketCap":2420952436},{"date":"2025-09-12","current":41.361413,"twenty":-10.162337,"median":-3.417502,"eighty":16.709109,"marketCap":2398961952},{"date":"2025-09-19","current":41.809495,"twenty":-10.162337,"median":-3.417502,"eighty":16.776195,"marketCap":2424950706},{"date":"2025-09-26","current":38.914196,"twenty":-10.162337,"median":-3.417502,"eighty":16.947295,"marketCap":2257023369},{"date":"2025-10-03","current":38.224839,"twenty":-10.162337,"median":-3.417502,"eighty":17.03964,"marketCap":2217040670},{"date":"2025-10-10","current":37.052932,"twenty":-10.162337,"median":-3.417502,"eighty":17.090583,"marketCap":2149070082},{"date":"2025-10-17","current":37.501014,"twenty":-10.162337,"median":-3.417502,"eighty":17.354431,"marketCap":2175058836},{"date":"2025-10-24","current":38.466114,"twenty":-10.162337,"median":-3.417502,"eighty":17.59682,"marketCap":2231034615},{"date":"2025-10-31","current":-178.753982,"twenty":-10.172486,"median":-3.448497,"eighty":17.810878,"marketCap":2145047787},{"date":"2025-11-07","current":-169.247209,"twenty":-10.219605,"median":-3.476395,"eighty":17.810878,"marketCap":2030966504},{"date":"2025-11-14","current":-174.244666,"twenty":-10.301936,"median":-3.504298,"eighty":17.810878,"marketCap":2090935987},{"date":"2025-11-21","current":-163.916588,"twenty":-10.6072,"median":-3.538772,"eighty":17.810878,"marketCap":1966999055},{"date":"2025-11-28","current":-180.408196,"twenty":-10.799451,"median":-3.540618,"eighty":17.810878,"marketCap":2164898350},{"date":"2025-12-05","current":-174.577829,"twenty":-11.1402,"median":-3.542049,"eighty":17.810878,"marketCap":2094933953},{"date":"2025-12-12","current":-179.90845,"twenty":-11.860354,"median":-3.542049,"eighty":17.810878,"marketCap":2158901402},{"date":"2025-12-19","current":-180.574778,"twenty":-12.666412,"median":-3.542049,"eighty":17.810878,"marketCap":2166897333},{"date":"2025-12-26","current":-181.074523,"twenty":-12.945597,"median":-3.542049,"eighty":17.810878,"marketCap":2172894281},{"date":"2026-01-02","current":-174.244666,"twenty":-13.160355,"median":-3.542049,"eighty":17.810878,"marketCap":2090935987},{"date":"2026-01-09","current":-185.738817,"twenty":-13.430949,"median":-3.542049,"eighty":17.810878,"marketCap":2228865799},{"date":"2026-01-16","current":-191.402601,"twenty":-13.900553,"median":-3.542049,"eighty":17.810878,"marketCap":2296831214},{"date":"2026-01-23","current":-193.06842,"twenty":-36.411218,"median":-3.542049,"eighty":17.810878,"marketCap":2316821042},{"date":"2026-01-30","current":-181.574269,"twenty":-42.996332,"median":-3.544901,"eighty":17.810878,"marketCap":2178891230},{"date":"2026-02-06","current":-186.07198,"twenty":-44.121622,"median":-3.546973,"eighty":17.810878,"marketCap":2232863765},{"date":"2026-02-13","current":-190.236528,"twenty":-45.253331,"median":-3.546973,"eighty":17.810878,"marketCap":2282838334},{"date":"2026-02-20","current":-190.236528,"twenty":-46.332575,"median":-3.546973,"eighty":17.810878,"marketCap":2282838334},{"date":"2026-02-27","current":-8.333483,"twenty":-46.332575,"median":-3.566587,"eighty":17.810878,"marketCap":2358375720},{"date":"2026-03-06","current":-8.041704,"twenty":-46.332575,"median":-3.581442,"eighty":17.810878,"marketCap":2275802360},{"date":"2026-03-13","current":-7.379865,"twenty":-46.332575,"median":-3.589648,"eighty":17.810878,"marketCap":2088501812},{"date":"2026-03-20","current":-7.481341,"twenty":-46.332575,"median":-3.589648,"eighty":17.810878,"marketCap":2117219505},{"date":"2026-03-27","current":-7.623572,"twenty":-46.332575,"median":-3.632324,"eighty":17.810878,"marketCap":2157470827},{"date":"2026-04-02","current":-7.381779,"twenty":-46.332575,"median":-3.670075,"eighty":17.810878,"marketCap":2089043580},{"date":"2026-04-10","current":-7.950703,"twenty":-46.332575,"median":-4.395912,"eighty":17.810878,"marketCap":2250048866},{"date":"2026-04-17","current":-7.950703,"twenty":-46.332575,"median":-4.654495,"eighty":17.810878,"marketCap":2250048866},{"date":"2026-04-24","current":-7.872476,"twenty":-46.332575,"median":-4.7273,"eighty":17.810878,"marketCap":2227910639},{"date":"2026-05-01","current":-10.736806,"twenty":-46.332575,"median":-4.787552,"eighty":17.810878,"marketCap":2308413282},{"date":"2026-05-08","current":-10.480181,"twenty":-46.332575,"median":-4.837762,"eighty":17.810878,"marketCap":2253238933},{"date":"2026-05-15","current":-10.208577,"twenty":-46.332575,"median":-4.837762,"eighty":17.810878,"marketCap":2194844001},{"date":"2026-05-22","current":-10.733054,"twenty":-46.332575,"median":-4.837762,"eighty":17.810878,"marketCap":2307606629},{"date":"2026-05-29","current":-11.398016,"twenty":-46.392533,"median":-4.816423,"eighty":17.848653,"marketCap":2450573531},{"date":"2026-06-05","current":-13.149396,"twenty":-46.332575,"median":-4.837762,"eighty":17.810878,"marketCap":2827120163},{"date":"2026-06-12","current":-13.449097,"twenty":-46.332575,"median":-4.837762,"eighty":17.810878,"marketCap":2891555950},{"date":"2026-06-18","current":-13.580217,"twenty":-46.332575,"median":-4.837762,"eighty":17.810878,"marketCap":2919746607},{"date":"2026-06-26","current":-13.645776,"twenty":-46.392533,"median":-4.816423,"eighty":17.848653,"marketCap":2933841935},{"date":"2026-07-02","current":-13.27115,"twenty":-46.392533,"median":-4.816423,"eighty":17.848653,"marketCap":2853297201},{"date":"2026-07-10","current":-13.243053,"twenty":-46.392533,"median":-5.159038,"eighty":17.848653,"marketCap":2847256346},{"date":"2026-07-17","current":-13.673873,"twenty":-46.392533,"median":-5.361788,"eighty":17.848653,"marketCap":2939882791},{"date":"2026-07-24","current":-13.664508,"twenty":-46.392533,"median":-5.472783,"eighty":17.848653,"marketCap":2937869172},{"date":"2026-07-31","current":-14.104694,"twenty":-46.400028,"median":-5.505341,"eighty":17.858097,"marketCap":3032509235},{"date":"2026-08-07","current":-17.727254,"twenty":-46.400028,"median":-5.52902,"eighty":17.858097,"marketCap":2889542332},{"date":"2026-08-14","current":-18.565123,"twenty":-46.400028,"median":-5.558619,"eighty":17.858097,"marketCap":3026115099},{"date":"2026-08-21","current":-19.540935,"twenty":-46.400028,"median":-5.614856,"eighty":17.858097,"marketCap":3185172380},{"date":"2026-08-28","current":-19.405062,"twenty":-46.400028,"median":-5.644455,"eighty":17.858097,"marketCap":3163025164}],"updateTime":1788216707275},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PK\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635249185","title":"Park Hotels & Resorts Is Maintained at Equal-Weight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2635249185","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635249185?lang=en_us&edition=fundamental","pubTime":"2026-05-13 01:15","pubTimestamp":1778606100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PK/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 12, 2026 13:15 ET (17:15 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PK","BK4218","BK4181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634217337","title":"Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2634217337","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634217337?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:31","pubTimestamp":1778592660,"startTime":"0","endTime":"0","summary":"sNDA submission follows agreement with FDA on confirmatory trial, a requirement of the accelerated approval pathway Confirmatory trial designed to demonstrate clinical benefit of mitapivat on reducing","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3293011/31990/en/Agios-Submits-sNDA-to-FDA-for-U-S-Accelerated-Approval-of-Mitapivat-in-Sickle-Cell-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4181","BK4218","PK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634721329","title":"Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2634721329","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634721329?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:00","pubTimestamp":1778583600,"startTime":"0","endTime":"0","summary":"Dosed first participant with OV4071, the first-ever oral potassium-chloride cotransporter 2 (KCC2) direct activator, in May 2026 in a Phase 1 study with healthy volunteersOV329 showed favorable safety","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3292680/0/en/Ovid-Therapeutics-Reports-Business-Updates-and-First-Quarter-2026-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256331488.USD","APA","BK4139","BK4585","BK4213","BK4007","BK4097","BK4588","BK4218","PK","BK4181","LENZ","BK4539","IS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634218216","title":"Press Release: Sionna Therapeutics Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2634218216","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634218216?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:00","pubTimestamp":1778583600,"startTime":"0","endTime":"0","summary":"Enrollment completed in the PreciSION CF Phase 2a proof-of-concept trial evaluating NBD1 stabilizer SION-719 as an add-on to standard of care in participants with cystic fibrosis; topline data on track for the summer of 2026. Ongoing Phase 1 trial evaluating NBD1 stabilizer SION-451 in proprietary dual combinations with SION-2222 and with SION-109 in healthy volunteers is also on track for topline data in the summer of 2026. Maintained strong cash position with approximately $289.9 million in cash and cash equivalents, expected to fund operations into 2028. \"We entered 2026 with strong execution across our programs, highlighted by the recent completion of enrollment in our proof-of-concept Phase 2a trial of SION-719, an important milestone for Sionna,\" said Mike Cloonan, President and Chief Executive Officer of Sionna. \"With both of our clinical stage NBD1 stabilizer programs on track for topline readouts this summer, we remain focused on advancing these first-in-class product candidat","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","BK4093","BK4181","BK4218","SOC","BK4213","PK","SION","CF","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634232653","title":"Erasca Reports First Quarter 2026 Business Updates and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2634232653","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634232653?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:01","pubTimestamp":1778529660,"startTime":"0","endTime":"0","summary":"Robust monotherapy efficacy and generally well-tolerated safety results observed during dose escalation for ERAS-0015 in both KRAS G12X NSCLC and PDAC reinforce best-in-class potential across RAS-targ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3292285/0/en/Erasca-Reports-First-Quarter-2026-Business-Updates-and-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","IE0031619046.USD","BK4187","BK4539","IE00B7SZL793.SGD","PK","IE00B66KJ199.SGD","BK4139","DCO","IE00B19Z4B17.USD","LU0566484027.USD","LU1559883803.SGD","ERAS","BK4181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634928323","title":"MBX Biosciences Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2634928323","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634928323?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:00","pubTimestamp":1778497200,"startTime":"0","endTime":"0","summary":"Preliminary blinded data from ongoing Phase 1 trial demonstrated mean weight loss of 7% (range 0-16%) at 8 weeks in first MAD Part B cohort (n=8, including 2 placebo) MBX 4291 generally well tolerated","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3291731/0/en/MBX-Biosciences-Provides-Obesity-Portfolio-Update-Including-Initial-Phase-1-Data-for-MBX-4291-Supporting-Potential-for-Once-Monthly-Dosing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBH","IE00B5TLWC47.USD","LU2413666699.HKD","LU1093756325.SGD","BK4548","LU2413666426.HKD","LU1093756168.USD","MTD","LU1721428933.USD","IE00BYQQ9H92.USD","MBX","BK4567","BK4121","IE00BFXG0V08.USD","BK4218","LU2211817866.USD","BK4007","PK","BK4181","BK4585","BK4588","LU0347712357.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634828842","title":"Press Release: Actuate Therapeutics Announces FDA Clearance of IND for Oral Elraglusib and Strategic Initiatives to Advance the Elraglusib Development Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2634828842","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634828842?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:00","pubTimestamp":1778497200,"startTime":"0","endTime":"0","summary":"-- Elraglusib oral tablet formulation to drive next-phase clinical. -- FDA cleared IND for Phase 1/2 study of oral elraglusib in advanced cancer. patients, with focus on metastatic melanoma, NSCLC, colorectal, and. pancreatic cancers with initiation planned for 2H 2026. To support this initiative, the Company recently received Investigational New Drug  clearance from FDA to conduct a Phase 1/2 study designed to demonstrate that a higher overall exposure to elraglusib can be achieved with the oral formulation compared to the IV formulation. The study will evaluate the safety and potential efficacy of the oral formulation as a monotherapy in solid tumor patients, including those with metastatic melanoma, NSCLC, colorectal, and pancreatic cancers, based on evidence of efficacy of the IV formulation in prior clinical studies and machine learning therapeutic target analyses.\"Advancing the elraglusib oral tablet is an important element to the success of our overall development strategy,\" sai","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4567","BK4139","IND","LABU","LU0347712357.USD","LU1093756325.SGD","LU2413666699.HKD","LU1721428933.USD","IE00BFXG0V08.USD","BK4588","LU2413666426.HKD","EMA","IE00BYQQ9H92.USD","MTD","LU2211817866.USD","BK4081","BK4533","IE00B5TLWC47.USD","BK4585","PK","BK4181","LU1093756168.USD","BK4121","BK4218","ACTU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179294583","title":"Live Broadcast Preview: Guangdong BA League - Meizhou vs. Qingyuan! Tonight, Witness the \"Qing-Mei\" Rivalry Face-Off","url":"https://stock-news.laohu8.com/highlight/detail?id=1179294583","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179294583?lang=en_us&edition=fundamental","pubTime":"2026-05-10 17:10","pubTimestamp":1778404256,"startTime":"0","endTime":"0","summary":"People often speak of the gentle, enduring bond of \"childhood sweethearts,\" but this time, we set aside sentimentality for pure competition. In the seventh round of the Guangdong BA regular season,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1435385759.SGD","BOED","BOEU","LU2326559502.SGD","BK4085","BK4564","BOEG","BK4181","LU1429558221.USD","BA","BK4585","IE000M9KFDE8.USD","BK4588","BK4187","PK","BK4551","BK4218","VS","BK4516"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633172937","title":"Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633172937","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633172937?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:05","pubTimestamp":1778184300,"startTime":"0","endTime":"0","summary":"Successfully dosed all four planned healthy volunteer SAD cohorts of ongoing ABS-201 HEADLINE trial; well-tolerated with favorable emerging safety data Preliminary pharmacokinetic (PK) modeling from H","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3290557/0/en/Absci-Reports-Business-Updates-and-First-Quarter-2026-Financial-and-Operating-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","BK4588","BK4181","BK4587","AIYY","BK4006","PK","CHAT","BK4543","ARTY","AIPO","AI","BK4528","BK4551","BK4585","AGIX","SID","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633814551","title":"Press Release: Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633814551","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633814551?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151600,"startTime":"0","endTime":"0","summary":"Phase 2a follow-up period data for RAP-219 in focal onset seizures  demonstrated sustained seizure reduction, including a 90% median reduction in clinical seizures over baseline in weeks 9-12. RAP-219 Phase 2 trial in bipolar mania topline results now expected in the fourth quarter of 2026, ahead of previous 1H 2027 guidance. Pipeline programs, including RAP-219 long-acting injectable formulation, RAP-219 in primary generalized tonic-clonic seizures, and <ALPHA>6<BETA>4 nAChR in chronic pain and migraine, continue to advance. Strategic collaboration and license agreement entered into with Tenacia Biotechnology to develop and commercialize RAP-219 in Greater China across indications. \"We entered 2026 with strong momentum across the RAP-219 development program, highlighted by compelling new follow-up Phase 2a data recently presented at AAN that further reinforces RAP-219's treatment effect in focal onset seizures and builds confidence as we enter our Phase 3 trials,\" said Abraham N. Cees","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PK","BK4218","AAN","RAPP","BK4178","BK4007","BK4181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633453731","title":"Climb Bio Reports First Quarter 2026 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2633453731","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633453731?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151600,"startTime":"0","endTime":"0","summary":"Robust B-cell depletion observed with budoprutug subcutaneous formulation in healthy volunteers, supporting continued development CLYM116 modeling and initial Phase 1 safety data to be presented at ER","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3289829/0/en/Climb-Bio-Reports-First-Quarter-2026-Financial-Results-and-Provides-Business-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4181","ITP","LU1169589451.USD","PD","PK","SLE","BK4199","BK4077","BK4218","BK4023","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633145354","title":"Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633145354","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633145354?lang=en_us&edition=fundamental","pubTime":"2026-05-07 18:59","pubTimestamp":1778151540,"startTime":"0","endTime":"0","summary":"- Full Top Line Results from Phase 1a SAD/MAD Trial of ATI-052 Exceed Aclaris’ Target Profile, Validating Potential Best-in-Class Potency Advantage and Opportunity for Extended Dosing - - Unique Dual ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3289773/37216/en/Aclaris-Therapeutics-Reports-First-Quarter-2026-Financial-Results-and-Provides-Corporate-and-Clinical-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSA","PD","BK4218","LU1169589451.USD","BK4023","AD","PK","ACRS","LU1169590202.USD","BK4007","BK4132","BK4181","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633483561","title":"Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2633483561","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633483561?lang=en_us&edition=fundamental","pubTime":"2026-05-07 18:15","pubTimestamp":1778148900,"startTime":"0","endTime":"0","summary":"Phase 1 clinical trial of SL-325 enrollment complete; data expected in the second quarter of 2026 –Phase 2 clinical trial of SL-325 in patients with Crohn’s disease expected to initiate in the third q","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3289733/0/en/Shattuck-Labs-Reports-First-Quarter-2026-Financial-Results-and-Recent-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4181","BK4218","STTK","PK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633247759","title":"OnKure Therapeutics Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633247759","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633247759?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:05","pubTimestamp":1778011500,"startTime":"0","endTime":"0","summary":"-- Announced nomination of OKI-355, a next-generation PI3Kα pan-mutant selective inhibitor candidate, in vascular anomalies -- Initiated a discovery research program to expand the company’s pipeline i","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/05/3288243/0/en/OnKure-Therapeutics-Reports-First-Quarter-2026-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","BK4218","BK4539","PK","LENZ","BK4007","BK4139","BK4181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632335539","title":"SPONTAN® Phase II interim data demonstrates rapid onset and pharmacokinetic profile addressing FDA Pre-IND requirements across adult and ≥65 populations","url":"https://stock-news.laohu8.com/highlight/detail?id=2632335539","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632335539?lang=en_us&edition=fundamental","pubTime":"2026-05-04 14:00","pubTimestamp":1777874400,"startTime":"0","endTime":"0","summary":"Median Tmax of 10 minutes for SPONTAN  versus 60 minutes for oral vardenafil , consistent with Phase I study.Interim data provide the key pharmacokinetic dataset requested by the FDA, including rapid absorption, repeat-dose profile, with no drug accumulation observed, and consistent pharmacokinetics across adult and geriatric populations.Pharmacokinetic profile in subjects ≥65 years comparable to adults in the dataset, addressing a key FDA Pre-IND requirement.Consistent safety profile observed, with no serious adverse events, no Grade 3 or 4 treatment-emergent adverse events, and no treatment-related discontinuations.Interim data are expected to inform the Company's planned FDA 505 regulatory pathway.SPONTAN Phase II study design. Randomised, three-way crossover  followed by multiple-dose evaluation .The interim results indicate that the Study has characterised the key pharmacokinetic parameters requested by the FDA, including rapid absorption, repeat-dose behaviour, and consistency ac","market":"us","thumbnail":"https://mma.prnewswire.com/media/2971713/image1.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2971713/image1.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/spontan-phase-ii-interim-data-demonstrates-rapid-onset-and-pharmacokinetic-profile-addressing-fda-pre-ind-requirements-across-adult-and-65-populations-302761066.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PK","LTP.AU","IND","BK4181","BK4218","BK4585","BK4588","BK7096","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632660377","title":"How Investors Are Reacting To Park Hotels & Resorts (PK) Q1 Beat, Guidance Shift And New Loan Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2632660377","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632660377?lang=en_us&edition=fundamental","pubTime":"2026-05-03 09:48","pubTimestamp":1777772923,"startTime":"0","endTime":"0","summary":"In late April 2026, Park Hotels & Resorts Inc. reported first quarter 2026 results showing revenue of US$622 million and a swing to net income of US$11 million, alongside funds from operations per share of US$0.45 that exceeded analyst expectations and an affirmed quarterly dividend of US$0.25 per share.\nThe company also modestly trimmed full-year net income guidance while raising RevPAR and profitability outlooks, underscoring how renovation-driven performance, non-core hotel sales, and a...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9621070-choice1-main-header/1585186786447","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9621070-choice1-main-header/1585186786447"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-pk/park-hotels-resorts/news/how-investors-are-reacting-to-park-hotels-resorts-pk-q1-beat","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-pk/park-hotels-resorts/news/how-investors-are-reacting-to-park-hotels-resorts-pk-q1-beat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4181","BK4211","PK","BK4218","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632648945","title":"Analysts Offer Insights on Real Estate Companies: Safehold (SAFE), Piedmont Office (PDM) and Park Hotels & Resorts (PK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632648945","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632648945?lang=en_us&edition=fundamental","pubTime":"2026-05-01 22:40","pubTimestamp":1777646446,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Real Estate sector with new ratings on Safehold (SAFE), Piedmont Office (PDM) and Park Hotels & Resorts...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-real-estate-companies-safehold-safe-piedmont-office-pdm-and-park-hotels-resorts-pk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-real-estate-companies-safehold-safe-piedmont-office-pdm-and-park-hotels-resorts-pk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PK","BK4218","SAFE","PDM","BK4223","BK4181","BK4084","BK4234","BK4194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632305662","title":"GUIDANCE: (PK) Park Hotels & Resorts Expects 2026 Adjusted FFO Range $1.74-$1.90, vs. FactSet Est of $1.84","url":"https://stock-news.laohu8.com/highlight/detail?id=2632305662","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632305662?lang=en_us&edition=fundamental","pubTime":"2026-05-01 05:25","pubTimestamp":1777584307,"startTime":"0","endTime":"0","summary":"GUIDANCE: (PK) Park Hotels & Resorts Expects 2026 Adjusted FFO Range $1.74-$1.90, vs. FactSet Est of $1.84","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PK","BK4218","BK4181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632866234","title":"Earnings Flash (PK) Park Hotels & Resorts Posts Q1 Adjusted FFO $0.45, vs. FactSet Est of $0.39","url":"https://stock-news.laohu8.com/highlight/detail?id=2632866234","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632866234?lang=en_us&edition=fundamental","pubTime":"2026-05-01 05:22","pubTimestamp":1777584157,"startTime":"0","endTime":"0","summary":"Earnings Flash (PK) Park Hotels & Resorts Posts Q1 Adjusted FFO $0.45, vs. FactSet Est of $0.39","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632866618","title":"Park Hotels & Resorts Q1 FFO $0.45 Beats $0.39 Estimate, Sales $622.000M Beat $611.238M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2632866618","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632866618?lang=en_us&edition=fundamental","pubTime":"2026-05-01 04:16","pubTimestamp":1777580218,"startTime":"0","endTime":"0","summary":"Park Hotels &amp; Resorts (NYSE:PK) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.39 by 15.38 percent. This is a 2.17 percent decrease over earnings of $0.46 per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/04/52196200/park-hotels-resorts-q1-ffo-0-45-beats-0-39-estimate-sales-622-000m-beat-611-238m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Park Hotels & Resorts Q1 FFO $0.45 Beats $0.39 Estimate, Sales $622.000M Beat $611.238M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PK","BK4181","BK4218"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":5,"totalSize":165,"code":"91000000","status":"200"}]}}